title: Surgical resection for hepatocellular carcinoma in the noncirrhotic: the Western experience.
abstract: Although hepatocellular carcinoma (HCC) is most often a sequela of severe hepatic fibrosis or cirrhosis, a proportion of cases arise in the  noncirrhotic patient. The gold standard therapy in such cases is surgical resection. Innovations in operative technique allow for this treatment to be implemented with very low mortality and acceptable morbidity at high-volume hepatobiliary centers. This chapter discusses various etiologies of noncirrhotic HCC and presents a large single-center experience that is compared to other Western series.
authors.affiliation: Department of Surgery, Mount Sinai School of Medicine, NewYork, NY 10029-6574, USA. myron.schwartz@mountsinai.org
authors.forename: Myron E
authors.initials: ME
authors.lastname: Schwartz
authors.forename: Brian
authors.initials: B
authors.lastname: Shrager
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000401:mortality / Q000601:surgery*; D055088:Early Detection of Cancer; D005234:Fatty Liver / Q000150:complications; D005260:Female; D006498:Hepatectomy; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology / Q000401:mortality / Q000601:surgery*; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D065626:Non-alcoholic Fatty Liver Disease; D012307:Risk Factors; D016896:Treatment Outcome